Varadan, V., Kamalakaran, S., Gilmore, H., Banerjee, N., Janevski, A., Miskimen, K., Williams, V., Basavanhalli, A., Madabhushi, A., Lezon-Geyda, K., Bossuyt, V., Lannin, D., Abu-Khalaf, M., Sikov, W., Dimitrova, N., & Harris, L.(2016).Brief-exposure to preoperative bevacizumab reveals a TGF-β signature predictive of response in HER2-negative breast cancers..International journal of cancer,138(3),747-57.
